The bioartificial kidney and bioengineered membranes in acute kidney injury

Nephron - Experimental Nephrology

Volumn 109, Issue 4, 2008, Pages

  Ding, Feng ^a,b   Humes, H David ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Acute kidney injury; Cell therapy; Inflammation; Nanotechnology; Tissue engineering; Tubule cells

Indexed keywords

ARTIFICIAL KIDNEY; ARTIFICIAL MEMBRANE; BIOENGINEERING; BIOREACTOR; CELL ACTIVITY; CELL SURVIVAL; CELL THERAPY; CLINICAL TRIAL; CONTINUOUS RENAL REPLACEMENT THERAPY; DIALYSIS; DISEASE MODEL; ENDOCRINE FUNCTION; HEMOFILTRATION; HUMAN; HYDRAULIC PERMEABILITY; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE; KIDNEY TUBULE CELL; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; SAFETY; SEPSIS; SOLUTE; TISSUE ENGINEERING;

ANIMALS; BIOARTIFICIAL ORGANS; BIOREACTORS; CLINICAL TRIALS AS TOPIC; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY TUBULES, PROXIMAL; KIDNEY, ARTIFICIAL; MEMBRANES, ARTIFICIAL; TISSUE ENGINEERING;

EID: 52449106411     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000142936     Document Type: Review

References (19)

1. Brady HR, Clarkson MR, Lieberthal W: Acute renal failure; in Brenner BM (ed): Brenner & Rector's The Kidney. Philadelphia, Saunders, 2004, pp 1215-1292.
2. Waikar SS, Liu KD, Chertow GM: The incidence and prognostic significance of acute kidney injury. Curr Opin Nephrol Hypertens 2007;16:227-236.
3. Kelly KJ: Acute renal failure: much more than a kidney disease. Semin Nephrol 2006; 26:105-113.
4. Simmons EM, Himmelfarb J, Sezer MT, Chertow GM, Mehta RL, Paganini EP, Soroko S, Freedman S, Becker K, Spratt D, Shyr Y, Ikizler TA; PICARD Study Group: Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 2004;65: 1357-1365.
5. Okusa MD: The inflammatory cascade in acute ischemic renal failure. Nephron 2002; 90:133-138.
6. Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL: Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 1998;32:107-114.
7. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS: Hypovitaminosis D in medical inpatients. N Engl J Med 1998;338:777-783.
8. Gage FH: Cell therapy. Nature 1998;392(6679 suppl):18-24.
9. Nikolovski J, Gulari E, Humes HD: Design engineering of a bioartificial renal tubule cell therapy device. Cell Transplant 1999;8: 351-364.
10. Humes HD, MacKay SM, Funke AJ, Buffington DA: Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics. Kidney Int 1999;55:2502-2514.
11. Humes HD, Buffington DA, MacKay SM, Funke AJ, Weitzel WF: Replacement of renal function in uremic animals with a tissue-engineered kidney. Nat Biotechnol 1999;17:451-455.
12. Humes HD, Fissell WH, Weitzel WF, Buffington DA, Westover AJ, MacKay SM, Gutierrez JM: Metabolic replacement of kidney function in uremic animals with a bioartificial kidney containing human cells. Am J Kidney Dis 2002;39:1078-1087.
13. Fissell WH, Dyke DB, Weitzel WF, Buffington DA, Westover AJ, MacKay SM, Gutierrez JM, Humes HD: Bioartificial kidney alters cytokine response and hemodynamics in endotoxin-challenged uremic animals. Blood Purif 2002;20:55-60.
14. Fissell WH, Lou L, Abrishami S, Buffington DA, Humes HD: Bioartificial kidney ameliorates gram-negative bacteria-induced septic shock in uremic animals. J Am Soc Nephrol 2003;14:454-461.
15. Humes HD, Buffington DA, Lou L, Abrishami S, Wang M, Xia J, Fissell WH: Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock. Crit Care Med 2003;31:2421-2428.
16. Humes HD, Buffington DA, Lou L, Wang M, Abrishami S: Renal cell therapy ameliorates pulmonary abnormalities in a large animal model of septic shock and acute renal injury. J Am Soc Nephrol 2007;18:A382.
17. Weitzel WF, Bartlett RH, Swaniker FC, Paganini EP, Luderer JR, Sobota J: Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int 2004;66: 1578-1588.
18. Tumlin J, Wali R, Williams W, Murray P, Tolwani AJ, Vinnikova AK, et al: Efficacy and safety of renal tubule cell therapy for acute renal failure. JASN 2008;19:1034-1040.
19. Fissell WH, Fleischman AJ, Humes HD, Roy S: Development of continuous implantable renal replacement: past and future. Transplant Res 2007;150:327-336.